Search

Search Constraints

You searched for: Author/Creator Salzer, Wanda

Search Results

2. Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54, 280 doses administered to 16, 534 patients on children's oncology group (COG) clinical trials. Issue 7 (3rd July 2018)

3. 18‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) evaluation of nodular lesions in patients with neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST)1. Issue 1 (29th May 2012)

4. Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Issue 5 (4th February 2014)